Video1_The mechanisms of potassium loss in acute myocardial ischemia: New insights from computational simulations.AVI by Jose M. Ferrero (6705797)

“…In addition, the formation of a [K+]o border zone of approximately 1.2 cm 15 min after the onset of ischemia is predicted by the model. …”

DataSheet1_The mechanisms of potassium loss in acute myocardial ischemia: New insights from computational simulations.docx by Jose M. Ferrero (6705797)

“…In addition, the formation of a [K+]o border zone of approximately 1.2 cm 15 min after the onset of ischemia is predicted by the model. …”

5-FU inhibits cell proliferation in cultures of smooth muscle cells. by Marcelo de Carvalho Filgueiras (408321)

“…(<b>D</b>) Quantification of the percentage of nuclei/field (black bars) and the number of phospho-histone H3-positive cells/field (gray bars) in each culture condition revealed a 40% decrease in phospho-histone H3-positive cells after 24 h of both 0.1 and 1 mM of 5-FU treatment. …”

EDA2 down-regulates activated EGFR and reduces cell viability. by Laura E. Hanold (705810)

“…<p>(a) Cells were stimulated with 50 ng/mL EGF for 5 min in the presence or absence of EDA peptides, followed by western blotting. …”

Supplementary Material for: Polypharmacy and the Progression of Chronic Kidney Disease: Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease by Min H.K. (10922121)

“…Polypharmacy was defined as taking 6 or more medications at the time of enrollment; renal events were defined as a ≥50% decrease in kidney function from baseline values, doubling of the serum creatinine levels, or initiation of renal replacement treatment. …”

STAD-2 reduces viability of <i>P</i>. <i>falciparum in vitro</i>. by Briana R. Flaherty (744995)

“…(<b>B</b>) Synchronous iRBC were treated with 1 μM STAD-2 or STAD-2 scramble, and parasitemia was determined by flow cytometry at 24, 48 and 72 hours post-treatment. A significant decrease in parasitemia was seen with STAD-2 treatment of both ring- and late-stage iRBC (2way ANOVA, p<0.001, n = 3, mean ± S.E., red = STAD-2/late, blue = STAD-2/ring, orange = STAD-2 scramble/late, green = STAD-2 scramble/ring). …”

Pearson correlation between various aspects of selenocysteine insertion sequences from the seed alignment of Rfam family RF00031 [23]. by Evan Senter (110590)

“…Using the Monte Carlo algorithm, we determined the mean first passage time (MFPT), defined as the average taken over 50 runs, of the number of Monte Carlo steps taken to fold the empty structure into the MFE structure, where an absolute upper bound of 5 million steps was allowed in the simulation. …”

<i>ACVR2</i> promoter hypermethylation and LOH in colon cancer specimens and the MSS HT29 cell line and correlation of <i>ACVR2</i> promoter hypermethylation and loss of <i>ACVR2</... by Barbara Jung (155690)

“…<p>A) ACVR2 promoter with map of positioning of MSP primers B) Using a CpG islands search program, we identified the CpG islands within the <i>ACVR2</i> promoter based upon following stringent criteria: ∼CG percentage>55%; observed CpG/expected CpG >0.65; length >500 bp. …”

SOX4 trans-activates the transcription of <i>SEMA3</i>, <i>Plexin</i>, and <i>NRP1</i>. by Hsin-Yi Huang (111181)

Supplementary Material for: Meta-analysis of the efficacy and safety of finerenone in diabetic kidney disease by Zheng Y. (4132180)

HuR silencing destabilizes <i>Cox-2</i> mRNA in CSE-exposed <i>AhR^−/−</i> lung fibroblasts. by Michela Zago (463762)

“…Results are expressed as mean ± SEM of three independent experiments. (D) There was a significant decline in <i>Cox-2</i> mRNA after exposure to ActD. …”

Stimulus-specific adaptation to behaviorally-relevant sounds in awake rats by Amit Yaron (210467)

Data Sheet 2_Global, regional, and national burden of acute glomerulonephritis in children and adolescents: 1990–2021 analysis and future projections.docx by Ming Liu (105953)

“…In 2021, there were approximately 170,584 new cases, representing a decrease compared to earlier years, with an age-standardized incidence rate (ASIR) of 6.47 per 100,000 (95% UI: 4.79–8.45). …”

Data Sheet 1_Global, regional, and national burden of acute glomerulonephritis in children and adolescents: 1990–2021 analysis and future projections.docx by Ming Liu (105953)

“…In 2021, there were approximately 170,584 new cases, representing a decrease compared to earlier years, with an age-standardized incidence rate (ASIR) of 6.47 per 100,000 (95% UI: 4.79–8.45). …”

Detection and quantification of transcription factor translocation into the nucleus in mouse livers. by Michaela Schlederer (125334)

“…Size bar: 50 µm. <b>B</b> Scattergram of the analyzed IHC samples used in A. …”

File contains the zipped set of figures for this paper in PNG format. by Piotr Borkowski (15195012)

“…Top: all eigenvectors. Bottom: 50 eigenvectors with the lowest eigenvalue. S4_5_Fig.png: S4_5_FigButtom.png: Relative error among the elements of eigenvector constituting its halfmass (standard error divided by the mean). …”

Image1_Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy.JPE... by Changzhen Ren (10649432)

“…However, it is not clear whether SGLT2 inhibitors have cardiovascular benefits in patients with cancer chemotherapy–related cardiac dysfunction. We aimed to determine whether empagliflozin (EMPA), an SGLT2 inhibitor, has a protective role against sunitinib (SNT)-induced cardiac dysfunction in a mouse model.…”

Image4_Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy.JPE... by Changzhen Ren (10649432)

“…However, it is not clear whether SGLT2 inhibitors have cardiovascular benefits in patients with cancer chemotherapy–related cardiac dysfunction. We aimed to determine whether empagliflozin (EMPA), an SGLT2 inhibitor, has a protective role against sunitinib (SNT)-induced cardiac dysfunction in a mouse model.…”

Image2_Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy.JPE... by Changzhen Ren (10649432)

“…However, it is not clear whether SGLT2 inhibitors have cardiovascular benefits in patients with cancer chemotherapy–related cardiac dysfunction. We aimed to determine whether empagliflozin (EMPA), an SGLT2 inhibitor, has a protective role against sunitinib (SNT)-induced cardiac dysfunction in a mouse model.…”

Image5_Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy.JPE... by Changzhen Ren (10649432)

“…However, it is not clear whether SGLT2 inhibitors have cardiovascular benefits in patients with cancer chemotherapy–related cardiac dysfunction. We aimed to determine whether empagliflozin (EMPA), an SGLT2 inhibitor, has a protective role against sunitinib (SNT)-induced cardiac dysfunction in a mouse model.…”